These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 11009210

  • 1. Tolerability of paroxetine in Parkinson's disease: a prospective study.
    Tesei S, Antonini A, Canesi M, Zecchinelli A, Mariani CB, Pezzoli G.
    Mov Disord; 2000 Sep; 15(5):986-9. PubMed ID: 11009210
    [Abstract] [Full Text] [Related]

  • 2. [Hallucinations caused by paroxetine taken together with a levodopa-carbidopa preparation].
    Freijzer PL, Brenninkmeijer JH.
    Ned Tijdschr Geneeskd; 2002 Mar 23; 146(12):574-5. PubMed ID: 11938583
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
    Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, Factor SA, Juncos J, Serrano Ramos C, Brodsky M, Manning C, Marsh L, Shulman L, Fernandez HH, Black KJ, Panisset M, Christine CW, Jiang W, Singer C, Horn S, Pfeiffer R, Rottenberg D, Slevin J, Elmer L, Press D, Hyson HC, McDonald W, SAD-PD Study Group.
    Neurology; 2012 Apr 17; 78(16):1229-36. PubMed ID: 22496199
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
    Mazeh D, Shahal B, Aviv A, Zemishlani H, Barak Y.
    Int Clin Psychopharmacol; 2007 Nov 17; 22(6):371-5. PubMed ID: 17917556
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical effects of serotonin reuptake inhibitors--a review].
    Feighner JP.
    Fortschr Neurol Psychiatr; 1994 Sep 17; 62 Suppl 1():9-15. PubMed ID: 7959528
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Focus on paroxetine.
    Green B.
    Curr Med Res Opin; 2003 Sep 17; 19(1):13-21. PubMed ID: 12661775
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression.
    Kasper S, Gastpar M, Möller HJ, Müller WE, Volz HP, Dienel A, Kieser M.
    Int Clin Psychopharmacol; 2010 Jul 17; 25(4):204-13. PubMed ID: 20568656
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.
    Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dubé EM.
    J Clin Psychiatry; 2002 Jul 17; 63(7):577-84. PubMed ID: 12143913
    [Abstract] [Full Text] [Related]

  • 16. [Hallucinations caused by paroxetine taken together with a levodopa-carbidopa preparation].
    Schölzel-Dorenbos CJ.
    Ned Tijdschr Geneeskd; 2002 Aug 31; 146(35):1663-4. PubMed ID: 12233164
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of Traditional Chinese Medicine Combined with Selective Serotonin Reuptake Inhibitors on the Treatment for Parkinson's Disease with Depression: A Systematic Review and Meta-Analysis.
    Feng ST, Wang XL, Wang YT, Yuan YH, Li ZP, Chen NH, Wang ZZ, Zhang Y.
    Am J Chin Med; 2021 Aug 31; 49(3):627-643. PubMed ID: 33657988
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
    Weihs KL, Settle EC, Batey SR, Houser TL, Donahue RM, Ascher JA.
    J Clin Psychiatry; 2000 Mar 31; 61(3):196-202. PubMed ID: 10817105
    [Abstract] [Full Text] [Related]

  • 20. Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Gao R, Zhao P, Yan K.
    Clin Drug Investig; 2024 Jul 31; 44(7):459-469. PubMed ID: 38960993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.